Keyphrases
Transforming Growth Factor-β
100%
Implant Materials
100%
Human Osteoblasts
100%
In Vitro Mineralization
100%
Cell Culture
22%
Type I Collagen
22%
Continuous Administration
22%
Calcium Content
22%
Saos-2
22%
Multiple Dose
11%
Quantitative PCR
11%
MRNA Level
11%
Alkaline Phosphatase
11%
Northern Blot Analysis
11%
Treatment Group
11%
Extracellular Matrix Protein 1 (ECM1)
11%
In Vitro Cells
11%
Cell Implantation
11%
Optimal Dose
11%
Biphasic Dose Response
11%
Osteocalcin
11%
Control Culture
11%
Human Osteosarcoma Cells
11%
Primary Osteoblasts
11%
Ti-6Al-4V (Ti64)
11%
Mineralization Model
11%
Accumulative Dose
11%
Saos-2 Osteoblasts
11%
Single Administration
11%
Biochemistry, Genetics and Molecular Biology
Osteoblast
100%
Mineralization
100%
TGF Beta 1
100%
Single Drug Dose
33%
Type I Collagen
22%
Cell Culture
22%
Reverse Transcription Polymerase Chain Reaction
11%
Multiple Drug Dose
11%
Dose Response
11%
Northern Blotting
11%
Optimal Drug Dose
11%
Alkaline Phosphatase
11%
Extracellular Matrix Proteins
11%
Scleroprotein
11%
Messenger RNA
11%
Osteocalcin
11%
Immunology and Microbiology
Mineralization
100%
Osteoblast
100%
Transforming Growth Factor Beta1
100%
Cell Culture
22%
Reverse Transcription Polymerase Chain Reaction
11%
Matrix Protein
11%
Multiple Drug Dose
11%
Northern Blotting
11%
Dose Response
11%
Optimal Drug Dose
11%
Extracellular Matrix
11%
Pharmacology, Toxicology and Pharmaceutical Science
Implant
100%
Transforming Growth Factor Beta1
100%
Cell Culture
22%
Collagen Type 1
22%
Alkaline Phosphatase
11%
Scleroprotein
11%
Osteocalcin
11%
Messenger RNA
11%
Treatment Group
11%
Material Science
Implant Material
100%
Osteoblast
100%
Ti-6Al-4V
16%
Phosphatase
16%
Reverse Transcription Polymerase Chain Reaction
16%
Food Science
Reverse Transcription Polymerase Chain Reaction
100%
Protein Matrix
100%